Lupus & antiphospholipid syndrome

Economic insecurities and patient-reported outcomes in patients with systemic lupus erythematosus in the USA: a cross-sectional analysis of data from the California Lupus Epidemiology Study

Lancet RheumatolPublished Cross-sectional study

Authors' conclusion

Having any economic insecurity was associated with worse outcomes for people with SLE regardless of poverty or education.

Study context

Population
Adults (≥18 years) with physician-confirmed systemic lupus erythematosus (SLE) recruited from rheumatology clinics, San Francisco Bay Area, CA, USA, 2015–2018228 (90%) women
Participants
252 adults
Exposure
Any economic insecurity vs no insecurity
  • Any insecurityn = 135
Outcome
PROs (PROMIS, Neuro-QoL Cognitive Function, PHQ-8, GAD-7) by economic insecurity
Methodological detailscohort data (California Lupus Epidemiology Study), multivariable linear regression adjusted for demographics, SLE disease characteristics and comorbidities
  • Cohort data (California Lupus Epidemiology Study)
  • Multivariable linear regression adjusted for demographics, SLE disease characteristics and comorbidities

Main finding

As reported in the abstract

Physical function (PROMIS), adjusted mean score

No insecurity

48.9

adjusted mean · 95% CI 47.5–50.3

Any insecurity

45.7

adjusted mean · 95% CI 44.3–47.0

P = 0.0017

Observational data: associations, not effects.

Further findings

Adjusted mean

OutcomeAny insecurityNo insecurityP value
Pain interference, adjusted mean score54.4 (95% CI 53.0–55.8)52.0 (95% CI 50.5–53.5)P = 0.031
Fatigue, adjusted mean score54.9 (95% CI 53.3–56.5)50.5 (95% CI 48.8–52.3)P = 0.0005
Sleep disturbance, adjusted mean score52.9 (95% CI 51.4–54.5)49.9 (95% CI 48.3–51.6)P = 0.012
Cognitive function, adjusted mean score45.6 (95% CI 44.1–47.0)49.3 (95% CI 47.7–50.9)P = 0.0011
PHQ-8, adjusted mean score6.1 (95% CI 5.4–6.8)4.4 (95% CI 3.6–5.1)P = 0.0013
GAD-7, adjusted mean score5.2 (95% CI 4.5–5.9)3.3 (95% CI 2.6–4.1)P = 0.0008

Original publication

Economic insecurities and patient-reported outcomes in patients with systemic lupus erythematosus in the USA: a cross-sectional analysis of data from the California Lupus Epidemiology Study. Lancet Rheumatol. Published 20 December 2023. doi:10.1016/s2665-9913(23)00296-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.